Biopharm Talent Consulting provides a value added resource to Pharmaceutical Companies, Biotechs, CROs and Consultancies when engaging key professionals. People are the cornerstone of bringing a drug or device to market, from initial discovery through to post marketing. It can be a costly journey, with no guarantee of success, but having the right talent in place at all stages can save valuable time and millions in costs.
Biopharm Talent Consulting has an extensive international network of professionals within Pharmas, Biotechs, CROs and Consultancies and, by working closely with the hiring community, is well placed to attract and engage skilled, motivated individuals across the product lifecycle, covering:
• Medical Affairs • Clinical Research • Regulatory Affairs • HEOR / Market Access / Real World Evidence / Epidemiology • Pharmacovigilance / Drug Safety • Biostatistics • Clinical Data • Product / Brand Management • Sales
Clinical Researcher of the Year - The Americas: Make your mark in 2018
on 15th December 2017 at 9:11 am
The 2018 competition is well underway. Hundreds of competitors have completed Stage 1, a multiple-choice questionnaire testing knowledge of Good Clinical Practice. […]
International Clinical Researcher of the Year: Are you allowing yourself enough time?
on 15th December 2017 at 8:57 am
The deadline for entry to the prestigious PharmaTimes International Clinical Researcher of the Year 2018 is 31 January, so don’t delay, head over to the website today to register your details and get started on the Multiple-Choice Questionnaire. […]
NICE recommends Imbruvica for some MCL patients
on 15th December 2017 at 6:45 am
It is looking likely that a subgroup of patients with mantle cell lymphoma (MCL) will get routine access to Janssen’s Imbruvica on the NHS. […]
Shire and partners launch Irish haemophilia study
on 15th December 2017 at 6:38 am
Shire, the Royal College of Surgeons Ireland (RCSI) and Science Foundation Ireland (SFI), in collaboration with the Irish Haemophilia Society, have initiated a new study that aims to better personalise the care of haemophilia patients. […]